Transcriptomic analysis reveals differential gene expression in African American prostate cancer samples

Prostate cancer is the most frequent cancer in men in the Western world, and its incidence is rapidly increasing. In addition, population-based studies demonstrate that African Americans in the United States have an increased risk of developing prostate cancer. Despite advances in diagnosis and treatment, the molecular mechanisms underlying prostate cancer disparity in African American are not fully understood yet. In this whitepaper from Beckman Coulter Life Sciences, explore a proof of principle study to identify transcriptomic signatures in the African American population using FFPE and fresh frozen samples.